Anticancer drug isolated from green veg

13 November 2006

A team of UK scientists have isolated the anticancer properties in Brussels sprouts and cabbage. According to data published in the October issue of the journal Carcinogenesis, a chemical in these vegetables can kill breast cancer cells when combined with common anticancer drugs.

Scientists at the UK's University of Leicester studied the effects of the compound indole-3-carbinol on tumor cells. The cells were administered with between 300mg and 400mg of this naturally-occuring compound each day until, together with common chemotherapy drugs, the tumor cells started to die.

Several epidemological studies have implicated eating vegetables and protection from cancer, but the present research is the first to examine the mechanism of this protection. Indole-3-carbinol is present in vegetables belonging to the mustard family, which includes broccoli, watercress, cauliflower and kale, though higher concentrations are found in Brussels sprouts and cabbage, the researchers noted.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight